Literature DB >> 31345331

Lung Cancer in Slovenia.

Matjaž Zwitter1, Tanja Čufer2, Martina Vrankar3, Izidor Kern2, Tomaž Štupnik4, Aleš Rozman2, Helena Koprivnikar5, Vesna Zadnik3.   

Abstract

Entities:  

Year:  2019        PMID： 31345331     DOI： 10.1016/j.jtho.2019.02.025

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  4 in total

Review 1.  Thoracic surgery in Slovenia.

Authors:  Tomaž Štupnik
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

2.  Real-life long-term outcomes of upfront surgery in patients with resectable stage I-IIIA non-small cell lung cancer.

Authors:  Marko Bitenc; Tanja Cufer; Izidor Kern; Martina Miklavcic; Sabrina Petrovic; Vida Groznik; Aleksander Sadikov
Journal:  Radiol Oncol       Date:  2022-08-14       Impact factor: 4.214

3.  Real-world outcomes, treatment patterns and T790M testing rates in non-small cell lung cancer patients treated with first-line first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors from the Slovenian cohort of the REFLECT study.

Authors:  Nina Turnsek; Rok Devjak; Natalija Edelbaher; Ilonka Osrajnik; Mojca Unk; Dusanka Vidovic; Tina Jeric; Urska Janzic
Journal:  Radiol Oncol       Date:  2022-08-14       Impact factor: 4.214

4.  Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe.

Authors:  Denis Horgan; Giuseppe Curigliano; Olaf Rieß; Paul Hofman; Reinhard Büttner; Pierfranco Conte; Tanja Cufer; William M Gallagher; Nadia Georges; Keith Kerr; Frédérique Penault-Llorca; Ken Mastris; Carla Pinto; Jan Van Meerbeeck; Elisabetta Munzone; Marlene Thomas; Sonia Ujupan; Gilad W Vainer; Janna-Lisa Velthaus; Fabrice André
Journal:  J Pers Med       Date:  2022-01-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.